The Sepsis Diagnostics Market has emerged as a critical segment within the global healthcare and in-vitro diagnostics industry, driven by the urgent need for early disease detection and improved ...
A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.
The latent TB testing market presents opportunities through government support, tech advances in multiplex and molecular diagnostics, POC testing, telemedicine, and personalized medicine. These ...
Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality Results Today, Visby Medical announced two new relationships that will expand national access to the Visby ...
For people with food sensitivities, dining out can be a hassle at best and dangerous at worst. But soon, a new portable gadget the size of a mass-market paperback could allow you to quickly test meals ...
Roche has secured regulatory green lights in both the U.S. and Europe to begin shipping its first point-of-care test for whooping cough amid a worldwide surge in cases and the recent deaths of infants ...
Late-night cravings aren’t the only thing DoorDash can help with. Starting this week, women can order a first-of-its-kind, at-home swab test for three common sexually transmitted infections and have ...
As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...
Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results